摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氟-3-硝基吡啶 | 1480-87-1

中文名称
2-氟-3-硝基吡啶
中文别名
——
英文名称
2-fluoro-3-nitropyridine
英文别名
——
2-氟-3-硝基吡啶化学式
CAS
1480-87-1
化学式
C5H3FN2O2
mdl
MFCD03095068
分子量
142.089
InChiKey
QDKIYDGHCFZBGC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    18℃
  • 沸点:
    110℃/10mm
  • 密度:
    1.439±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    58.7
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi,T
  • 安全说明:
    S26
  • 危险类别码:
    R20/21/22
  • 海关编码:
    2933399090
  • 危险类别:
    IRRITANT
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    存放于惰性气体中,以避免与空气接触。

SDS

SDS:1c5c81b7ef594449f11585053b7c45b6
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Fluoro-3-nitropyridine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H314: Causes severe skin burns and eye damage
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P310: Immediately call a POISON CENTER or doctor/physician

Section 3. Composition/information on ingredients.
Ingredient name: 2-Fluoro-3-nitropyridine
CAS number: 1480-87-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H3FN2O2
Molecular weight: 142.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN3261 Class: 8 Packing group: II
Proper shipping name: CORROSIVE SOLID, ACIDIC, ORGANIC, N.O.S. (2-Fluoro-3-nitropyridine)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    2-氟-3-硝基吡啶盐酸铁粉氯化铵 作用下, 以 乙醇二甲基亚砜 为溶剂, 反应 3.0h, 生成 3-甲基-3H-咪唑并[4,5-b]吡啶
    参考文献:
    名称:
    Cu催化苯并咪唑与艾伦的C-H烯丙基化
    摘要:
    已经描述了 CuH 催化的苯并咪唑与丙二烯的分子内环化和分子间烯丙基化。在Cu(OAc) 2 /Xantphos的催化体系和催化量的(MeO) 2 MeSiH的作用下,反应顺利进行。该协议具有温和的反应条件和对带有吸电子、给电子或电子中性基团的底物的良好耐受性。针对该氢化铜催化体系提出了一种新的催化机理。
    DOI:
    10.1021/acs.orglett.1c02346
  • 作为产物:
    描述:
    2-氨基-3-硝基吡啶氟化氢吡啶 、 sodium nitrite 作用下, 以97%的产率得到2-氟-3-硝基吡啶
    参考文献:
    名称:
    氟化氢与碱结合,通过氨基芳烃的脱氨基氟化,轻松制备芳族氟化物
    摘要:
    通过将氟化氢与碱溶液结合使用,成功地实现了包括杂芳族化合物在内的氨基芳烃的一锅式脱氨氟化,即氨基芳烃的重氮化,然后将相应的重氮离子进行原位氟脱氮,以高产率生产了氟芳烃。已发现重氮化阶段在有效生产氟代芳烃中起着最重要的作用。它受到HF溶液组成的极大影响,并通过在谨慎控制的条件下使用适量的碱(例如吡啶)来增强。光化学方法有效地促进了氟脱重氮化阶段,从而以高收率提供了具有极性取代基(如羟基,硝基等)的氟代芳烃。
    DOI:
    10.1016/0040-4020(95)00867-8
点击查看最新优质反应信息

文献信息

  • [EN] SULFOXIMINE SUBSTITUTED PYRROLOTRIAZINES FOR PHARMACEUTICAL COMPOSITIONS<br/>[FR] PYRROLOTRIAZINES À SUBSTITUTION SULFOXIMINE POUR COMPOSITIONS PHARMACEUTIQUES
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2015091156A1
    公开(公告)日:2015-06-25
    This invention relates to novel sulfoximine substituted pyrrolotriazine derivatives of formula wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1 a or MNK1 b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1 a or MNK1 b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
    这项发明涉及一种新型的噻氧亚胺取代吡咯三嗪衍生物,其化学式中Ar、R1和R2的定义如描述和权利要求中所定义,并且它们作为MNK1(MNK1 a或MNK1 b)和/或MNK2(MNK2a或MNK2b)激酶抑制剂的用途,含有这些化合物的药物组合物,以及将其用作治疗或改善MNK1(MNK1 a或MNK1 b)和/或MNK2(MNK2a或MNK2b)介导的疾病的药剂的方法。
  • [EN] IMIDAZOLYL-IMIDAZOLES AS KINASE INHIBITORS<br/>[FR] IMIDAZOLYL-IMIDAZOLES EN TANT QU'INHIBITEURS DE KINASE
    申请人:GLAXO GROUP LTD
    公开号:WO2011123609A1
    公开(公告)日:2011-10-06
    Disclosed are compounds having the formula: wherein R1A, R1B, R2 and R3 are as defined herein, and methods of making and using the same.
    揭示了具有以下公式的化合物:其中R1A、R1B、R2和R3如本文所定义,并且制备和使用这些化合物的方法。
  • Photoredox Catalyzed Dealkylative Aromatic Halogen Substitution with Tertiary Amines
    作者:Dmitry L. Lipilin、Alexander E. Frumkin、Alexey Y. Tyurin、Vitalij V. Levin、Alexander D. Dilman
    DOI:10.3390/molecules26113323
    日期:——
    A reaction of aromatic halides bearing electron-withdrawing groups with tertiary amines in the presence of an iridium catalyst under blue light irradiation is described. Products of the aromatic substitution of the halide by the dialkylamino fragment are obtained. The interaction of aryl radicals with tertiary amines to generate zwitterionic radical species is believed to be the key factor responsible
    描述了带有吸电子基团的芳香族卤化物与叔胺在铱催化剂存在下在蓝光照射下的反应。获得卤化物被二烷基氨基片段芳族取代的产物。芳基自由基与叔胺相互作用产生两性离子自由基物种被认为是影响反应效率的关键因素。
  • Heteroaryl compounds as P2Y1 receptor inhibitors
    申请人:Sutton C. James
    公开号:US20060173002A1
    公开(公告)日:2006-08-03
    The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y 1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y 1 receptor activity.
    本发明提供了新颖的杂环芳基化合物及其类似物,这些化合物是人类P2Y1受体的选择性抑制剂。该发明还提供了相应的各种药物组合物以及调节P2Y1受体活性治疗对其敏感的疾病的方法。
  • Saturated Heterocyclic Aminosulfonyl Fluorides: New Scaffolds for Protecting-Group-Free Synthesis of Sulfonamides
    作者:Sergey A. Zhersh、Oleksandr P. Blahun、Iryna V. Sadkova、Andrey A. Tolmachev、Yurii S. Moroz、Pavel K. Mykhailiuk
    DOI:10.1002/chem.201801140
    日期:2018.6.12
    salts. The compounds were found to be stable upon storage and could be used for the protectinggroup‐free synthesis of sulfonamides. In the presence of the −SO2F group, the nitrogen atom could be modified by means of acylation, arylation, or reductive amination to give products that have high potential for the synthesis of bioactive compounds.
    合成了环状饱和氨基磺酰氟盐酸盐作为HCl盐。发现该化合物在储存时稳定,可用于无保护基团的磺酰胺合成。在-SO 2 F基团的存在下,氮原子可通过酰化,芳基化或还原性胺化进行修饰,以产生具有高潜力合成生物活性化合物的产物。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台